CM Wealth Advisors LLC bought a new stake in AtriCure, Inc. (NASDAQ:ATRC – Free Report) in the first quarter, Holdings Channel.com reports. The institutional investor bought 9,924 shares of the medical device company’s stock, valued at approximately $419,000. A number of other hedge funds also recently modified their holdings of the business. SG Americas Securities […]
AtriCure, Inc. (NASDAQ:ATRC – Get Free Report) saw a significant decline in short interest during the month of June. As of June 30th, there was short interest totalling 1,140,000 shares, a decline of 22.4% from the June 15th total of 1,470,000 shares. Based on an average daily trading volume, of 266,700 shares, the days-to-cover ratio […]
AtriCure (NASDAQ:ATRC – Get Free Report) had its price objective raised by equities researchers at BTIG Research from $55.00 to $56.00 in a research report issued to clients and investors on Monday, FlyOnTheWall reports. BTIG Research’s price target indicates a potential upside of 3.19% from the stock’s current price. Several other brokerages have also commented […]
AtriCure, Inc. (NASDAQ:ATRC – Get Rating) has been assigned an average recommendation of “Buy” from the five brokerages that are currently covering the stock, MarketBeat Ratings reports. Five investment analysts have rated the stock with a buy recommendation. The average 12-month target price among brokerages that have issued a report on the stock in the […]
AtriCure, Inc. (NASDAQ:ATRC – Get Rating) Director Maggie Yuen sold 4,313 shares of the stock in a transaction dated Friday, May 26th. The stock was sold at an average price of $47.04, for a total transaction of $202,883.52. Following the completion of the sale, the director now directly owns 4,682 shares in the company, valued […]